Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Senolytics To Alleviate Mobility Issues and Neurological Impairment in Aging

NCT05422885 is registered in ClinicalTrials.gov with Lewis Lipsitz as lead sponsor.

NCT NCT05422885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05422885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Senolytics To Alleviate Mobility Issues and Neurological Impairment in Aging
Lead sponsor
Lewis Lipsitz
Phase
Phase 1/2
Overall status
Completed
Start date
May 20, 2022
Completion date
January 24, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging